Last Updated:
Name Designation Appointment Date Status
Koothanil Narayanan Murali

Appointed as Director since May 2009

Director 13-May-2009 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Gokul Das Chedempath

Appointed as Managing Director since May 2009

Managing Director 13-May-2009 Current

People Timeline

Explore the timeline of key personnel in Agnus Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Door No.28/306 F-15, Ist Floor, Kairalee Complex Thondayad, Chevayoor Post, Kozhikode Kerala, 673017, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 673017
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Agnus Pharmaceuticals Private Limited?
You can contact Agnus Pharmaceuticals Private Limited through their registered address at Door No.28/306 F-15, Ist Floor, Kairalee Complex Thondayad, Chevayoor Post, Kozhikode Kerala, 673017, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Agnus Pharmaceuticals Private Limited?
The current directors of Agnus Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • KOOTHANIL NARAYANAN MURALI
  • GOKUL DAS CHEDEMPATH
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available